Taxifolin Attenuates Bacterial Pathogenicity and Thereby Enhances Antibacterial Efficacy in Clinically Relevant Bacteria
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219469 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ji-Hyun Yoon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biotechnology, Kyung Hee University, Seocheon, Giheung, Yongin 17104, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Quercetin, Biofilms, Anti-Bacterial Agents, Bacteria. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korea Health Technology R&D Project through the Korea Health Industry Development Institute, Ministry of Health & Welfare.
Abstract (Originalsprache)
Biofilm formation is an important pathogenic process that contributes to bacterial virulence, persistence, and reduced susceptibility to antimicrobial treatment. Therefore, taxifolin was evaluated as a potential antibiofilm agent. Taxifolin was assessed for its effects on biofilm formation, planktonic growth, antibiotic susceptibility, and the expression of biofilm- and virulence-associated genes. Taxifolin inhibited biofilm formation by Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Streptococcus mutans, Streptococcus sobrinus, Staphylococcus aureus, Pseudomonas aeruginosa, Cutibacterium acnes, and Porphyromonas gingivalis (IC50, 0.065~0.79 µg/mL). In E. faecalis and E. faecium, taxifolin did not substantially affect planktonic growth at 10 µg/mL. Taxifolin enhanced the antibacterial activity of commercially available antibiotics, and downregulated the expression of cytolysin-associated genes (cylR, cylM, and cylLs), quorum-sensing genes (fsrB and fsrC), biofilm-associated genes (gelE, acm, scm, ebpA, ebpB and bps), and the biofilm-associated virulence gene Esp. Taxifolin inhibited biofilm formation, enhanced bacterial susceptibility, and attenuated virulence-associated gene expression, supporting its potential as an adjunctive antibiofilm therapy for the management of biofilm-associated bacterial infections. Further studies are required to define its mechanism of action, activity against established biofilms, pharmacological properties, safety, and efficacy in appropriate in vivo models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Biotechnology, Kyung Hee University, Seocheon, Giheung, Yongin 17104, Gyeonggi-do, Republic of Korea.
- Major in Bio-Cosmetic Engineering, Division of Convergence Studies, Sungkyul University, 53 Sungkyuldaehak-ro, Manan-gu, Anyang-si 14097, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Ji-Hyun Yoon, Ki-Young Kim
Förderung
- Korea Health Industry Development Institute
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute
- Ministry of Health & Welfare
Zitieren
APA
Yoon, J. H., Kim, Y. J., & Kim, K. Y. (2026). Taxifolin Attenuates Bacterial Pathogenicity and Thereby Enhances Antibacterial Efficacy in Clinically Relevant Bacteria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219469
Vancouver
Yoon JH, Kim YJ, Kim KY. Taxifolin Attenuates Bacterial Pathogenicity and Thereby Enhances Antibacterial Efficacy in Clinically Relevant Bacteria. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219469
BibTeX
@article{Yoon2026,
author = {Yoon, Ji-Hyun and Kim, Yeo-Jin and Kim, Ki-Young},
title = {Taxifolin Attenuates Bacterial Pathogenicity and Thereby Enhances Antibacterial Efficacy in Clinically Relevant Bacteria},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219469}
}
EUVIMED